DERENZINI, ENRICO

DERENZINI, ENRICO  

Dipartimento di Scienze della Salute  

Mostra records
Risultati 1 - 20 di 83 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 1-gen-2020 Derenzini, EnricoMazzara, SaveriaFabbri, MarcoFiori, StefanoCabras, AntonelloPruneri, GiancarloRambaldi, AlessandroCorradini, PaoloTarella, Corrado + Article (author) -
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma 1-gen-2008 Perrotti A.Derenzini E. + Article (author) -
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma 1-gen-2011 Derenzini E. + Article (author) -
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients 1-gen-2008 Derenzini E. + Article (author) -
A phase ii trial of short course fludarabine, mitoxantrone, rituximab followed by 90y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma 1-gen-2012 Derenzini E. + Article (author) -
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 1-gen-2013 Derenzini E. + Article (author) -
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: Retrospective monocentric analysis of 14 patients 1-gen-2013 Derenzini E. + Article (author) -
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy 1-ago-2022 Derenzini, Enrico + Article (author) -
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis : a case report and a review of literature 1-gen-2013 Derenzini, Enrico + Article (author) -
Association of essential thrombocythemia and non-Hodgkin lymphoma: A single-centre experience 1-gen-2009 Derenzini E. + Article (author) -
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin 1-gen-2013 Derenzini E. + Article (author) -
Bendamustine: Role and evidence in lymphoma therapy, an overview 1-gen-2014 Derenzini E. + Article (author) -
BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors 1-ago-2018 Derenzini E.Valli D. + Article (author) -
Blastic plasmacytoid dendritic cell neoplasm : State of the art and prospects 1-mag-2019 Derenzini E. + Article (author) -
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: A multicenter retrospective study 1-gen-2013 Derenzini E. + Article (author) -
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma : the Italian experience and results of its use in daily clinical practice outside clinical trials 1-ago-2013 ANASTASIA, ANTONELLAP. CorradiniA.M. GianniE. Derenzini + Article (author) -
Bronchus-associated lymphoid tissue lymphomas : an update of a rare extranodal maltoma 1-nov-2007 L. SpaggiariE. Derenzini + Article (author) -
Characterization of a c-Rel inhibitor that mediates anticancer properties in hematologic malignancies by blocking NF-κB-controlled oxidative stress responses 1-gen-2016 Derenzini E. + Article (author) -
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics 1-lug-2022 Guidetti, AnnaBramanti, StefaniaMorello, LuciaDerenzini, EnricoCorradini, Paolo + Article (author) -
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 1-ott-2020 Merli F.Cairoli R.Galimberti S.Falini B.Derenzini E.Conconi A.Cuccaro A.Bocchia M.Marchesi F.Federici A. B.Venditti A.Oberti M.Corradini P. + Article (author) -